Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis
Therapeutic success of VEGF-based anti-angiogenic tumor therapy is limited due to resistance. Thus, new strategies for anti-angiogenic cancer therapy based on novel targets are urgently required. Our previous in vitro work suggested that small molecule Cdk5 inhibitors affect angiogenic processes suc...
Main Authors: | Merk, Henriette, Zhang, Siwei, Lehr, Thorsten, Müller, Christoph, Ulrich, Melanie, Bibb, James A., Adams, Ralf H., Bracher, Franz, Zahler, Stefan, Vollmar, Angelika M., Liebl, Johanna |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868742/ |
Similar Items
-
Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors
by: Weitensteiner, Sabine B., et al.
Published: (2013) -
Cdk5 and Foxc2 – a new relationship in the lymphatic vasculature
by: Liebl, Johanna
Published: (2015) -
Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma
by: Herzog, Julia, et al.
Published: (2016) -
Anti-leukemic effects of the V-ATPase inhibitor Archazolid A
by: Zhang, Siwei, et al.
Published: (2015) -
Cdk5 and the mystery of synaptic vesicle endocytosis
by: Nguyen, Chan, et al.
Published: (2003)